Company Filing History:
Years Active: 2024
Title: Shilpak Chatterjee: Innovator in Anti-Tumor Immunotherapy
Introduction
Shilpak Chatterjee is a notable inventor based in Charleston, SC (US). He has made significant contributions to the field of immunotherapy, particularly in cancer treatment. His innovative work focuses on the metabolic processes that can enhance anti-tumor responses.
Latest Patents
Chatterjee holds a patent titled "CD38-NAD+ regulated metabolic axis in anti-tumor immunotherapy." This patent outlines methods for producing hybrid Th1/Th17 cells and provides novel approaches for treating cancer by targeting the CD38-mediated metabolic axis. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Shilpak Chatterjee is affiliated with the MUSC Foundation for Research Development, where he continues to explore innovative solutions in cancer therapy. His work is characterized by a strong focus on the intersection of metabolism and immunology, which is crucial for developing effective treatments.
Collaborations
Chatterjee collaborates with fellow researcher Shikhar Mehrotra, enhancing the scope and impact of their research endeavors. Their partnership exemplifies the collaborative spirit necessary for breakthroughs in complex fields like immunotherapy.
Conclusion
Shilpak Chatterjee's contributions to anti-tumor immunotherapy highlight the importance of innovation in medical research. His work not only advances scientific understanding but also holds promise for improving cancer treatment outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.